Low Intensity Focused Ultrasound for Non-invasive and Reversible Deep Brain Neuromodulation—A Paradigm Shift in Psychiatric Research

Abstract

This article describes an emerging non-invasive neuromodulatory technology, called low intensity focused ultrasound (LIFU). This technology is potentially paradigm shifting as it can deliver non-invasive and reversible deep brain neuromodulation through acoustic sonication, at millimeter precision. Low intensity focused ultrasound's spatial precision, yet non-invasive nature sets it apart from current technologies, such as transcranial magnetic or electrical stimulation and deep brain stimulation. Additionally, its reversible effects allow for the causal study of deep brain regions implicated in psychiatric illness. Studies to date have demonstrated that LIFU can safely modulate human brain activity at cortical and subcortical levels. Due to its novelty, most researchers and clinicians are not aware of the potential applications and promise of this technique, underscoring the need for foundational papers to introduce the community to LIFU. This mini-review and synthesis of recent advances examines several key papers on LIFU administered to humans, describes the population under study, parameters used, and relevant findings that may guide future research. We conclude with a concise overview of some of the more pressing questions to date, considerations when interpreting new data from an emerging field, and highlight the opportunities and challenges in this exciting new area of study.

Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions

“…Targeting specific thalamic nuclei may provide an opportunity for broad clinical impact. Emerging treatment modalities such as focused ultrasound, allowing deep brain neuromodulation of specific brain regions 342 , may provide a novel mechanism to modulate thalamic connectivity and function to treat schizophrenia.…”

Focused Ultrasound as Targeted Therapy for Colorectal Cancer: A Comprehensive Review

“…At a low-dose energy deposition (<55 • C), hyperthermia increases cellular permeability, enabling drug delivery using nanoparticles [15]. At a high-dose energy deposition (>55 • C), hyperthermia indices cause coagulative necrosis in cells, leading to cell death [16]. Thus, HIFU is used in contrast to LIFU, which uses a low-intensity pulsed ultrasound beam and causes a minimal rise in target tissue temperature with no harm to surrounding healthy tissues if parameters are in control.…”

Low-intensity focused ultrasound targeted microbubble destruction reduces tumor blood supply and sensitizes anti-PD-L1 immunotherapy

“…Therefore, UTMD demonstrates the great potential to convert ‘cold’ into ‘hot’ tumors through multiple immunomodulating mechanisms, thereby sensitizing cancer immunotherapy. Notably, low-intensity ultrasound combined with MBs holds undeniable advantages of efficiency and safety, precise targeting, clinical availability, and high penetration ( Arulpragasam et al, 2022 ), which enables it to be an ideal option to enhance ICB therapy.…”